Evaluation of Imaging Characteristics of [18F]PI-2620 PET in AD and PSP Patients Using High and Low Specific Activity

NCT04715750 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease
Progressive Supranuclear Palsy

Interventions

DRUG: [18F]-PI2620

Sponsor

Life Molecular Imaging GmbH

Collaborators

[object Object]